| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007106494A2 Methods and compositions for treatment of diastolic heart failure |
| 09/20/2007 | WO2007106467A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt |
| 09/20/2007 | WO2007106236A2 Pyrrolo-pyridine kinase modulators |
| 09/20/2007 | WO2007106063A2 Methods for increasing blood flow and/or promoting tissue regeneration |
| 09/20/2007 | WO2007106049A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 09/20/2007 | WO2007106034A1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007105621A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 09/20/2007 | WO2007105286A1 Blood lipid level-lowering agent |
| 09/20/2007 | WO2007105179A1 Cardioplegic solution |
| 09/20/2007 | WO2007105050A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007075964A3 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 09/20/2007 | WO2007061995A3 Biomarkers for statin-induced myopathy or rhabdomyolysis |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2007030581A3 Neuroprotectants |
| 09/20/2007 | WO2007002572A3 Nattokinase for reducing whole blood viscosity |
| 09/20/2007 | WO2006119736A3 Pdz-domain modulators |
| 09/20/2007 | WO2006017384A3 Indazoles useful in treating cardiovascular diseases |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | WO2003011823A3 Crfr1 selective ligands |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219210 Amidopyrazole Derivative |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219194 Phenylalanine derivatives |
| 09/20/2007 | US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure |
| 09/20/2007 | US20070219177 Agent for treatment of cerebral ischemic diseases |
| 09/20/2007 | US20070219121 Vasodilator pharmaceutical preparation and health food composition |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070218147 Peroxisome Proliferator-Activated Receptor (Ppar) Activator, and Drugs, Supplements, Functional Foods and Food Additives Using the Same |
| 09/20/2007 | US20070218137 Sustained release matrix systems for highly soluble drugs |
| 09/20/2007 | US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | DE102006012548A1 Substituierte Chromanol-Derivate und ihre Verwendung Substituted chromanol derivatives and their use |
| 09/20/2007 | CA2717249A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | CA2646438A1 Methods and compositions for treatment of diastolic heart failure |
| 09/20/2007 | CA2646240A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 09/20/2007 | CA2646235A1 Non-peptidic renin inhibitors nitroderivatives |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | CA2645712A1 Triazole derivative or salt thereof |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2644134A1 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thiophene-3-sulfonamide, sodium salt |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | CA2643209A1 Methods for increasing blood flow and/or promoting tissue regeneration |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/19/2007 | EP1835030A1 OB fusion protein compositions and methods |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity |
| 09/19/2007 | EP1834639A1 Remedial agent for fat toxicity |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833821A2 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
| 09/19/2007 | EP1833816A1 Substituted piperidines as renin inhibitors |
| 09/19/2007 | EP1833795A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 09/19/2007 | EP1833788A1 Process for preparing perindopril erbumine |
| 09/19/2007 | EP1833569A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 09/19/2007 | EP1833496A2 Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
| 09/19/2007 | EP1833480A2 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 09/19/2007 | EP1833474A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/19/2007 | EP1833466A1 Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine |
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1833306A1 Method of producing a palatability enhancer that can add health value to foodstuffs |
| 09/19/2007 | EP1673338B1 Fatty acid compounds, preparation and uses thereof |
| 09/19/2007 | EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | EP1511517B1 Formulation for parenteral administration of sodium channel blockers |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 09/19/2007 | EP1141003B1 Methods of activation of SGK by phosphorylation. |
| 09/19/2007 | CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/19/2007 | CN101039938A Diphenyl substituted alkanes as flap inhibitors |
| 09/19/2007 | CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101039930A 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 09/19/2007 | CN101039917A Process for preparing telmisartan |
| 09/19/2007 | CN101039664A Atmosphere alteration method, and air spray and spray device used therefor |
| 09/19/2007 | CN101039585A Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101037416A 2,5,6-three substitution pyrazine derivatives |
| 09/19/2007 | CN101037414A [(2-n-propyl-4-methyl-1H-Benzimidazole)6-radical] carboxamide-1-radical] methylbiphenyl compound, synthesizing method and usage |
| 09/19/2007 | CN101036786A Immunomodulation agent with adjuvant having function for treating atherosclerosis |
| 09/19/2007 | CN101036769A Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process |
| 09/19/2007 | CN101036759A Novel function of highland barley extractive |